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Abstract
Background: The determination of Intraepidermal Nerve Fiber Density (IENFD) in skin biopsy is
a useful method for the evaluation of different types of peripheral neuropathies. To allow a reliable
use of the method it is necessary to determine interobserver reliability. Previous studies dealing
with this topic used limited suitable statistical methods.
Methods: In the present study three observers determined the IENFD and estimated the staining
quality of the basement membrane for an adequate quantity of 120 skin biopsies (stained with
indirect immunofluorescence technique) from 68 patients. More adequate statistical methods like
intraclass correlation coefficient and Bland Altman Plot were chosen to estimate interobserver
reliability.
Results: We found an unexpected significant difference in IENFD between the observers (p <
0.05) and so the results of this study are not in line with the high interobserver reliability reported
before (intraclass correlation coefficient: 0.73). The Bland Altmann Plot showed a variance growing
with rising mean. The difference in IENFD between the observers and the resulting low
interobserver reliability is likely caused by different interpretations of the standard counting rules.
There was no significant difference in IENFD between observers for biopsies with a well-defined
basement membrane. Thus skin biopsies with an inexactly defined basement membrane should not
be used diagnostically for the determination of IENFD.
Conclusion: These results emphasise that standardisation of the method is extremely important
and at least two observers should analyse skin biopsies with critical IENFD near the cut-off values.
Background
Despite the fact that numerous patients in pain or neurol-
ogy departments are admitted for typical neuropathic
symptoms such as paraesthesia and dysaesthesia the con-
ventional diagnostic methods such as nerve conduction
studies and electromyography often do not show patho-
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logical findings [1-4]. Immunohistochemical illustration
of the intraepidermal nerve fibers (IENF) in skin biopsy
and quantitative sensory testing (QST) are two new diag-
nostic methods to objectify the disorders of some of these
patients [5]. In 2005 Lauria et al. published the guidelines
of the European Federation of Neurological Societies
(EFNS) on the use of skin biopsy and the determination
of IENF density (IENFD) in the diagnosis of peripheral
neuropathy [6]. For a reliable use of this method, a check
of methodical quality criteria is essential. Especially relia-
bility as a degree of methodical accuracy has to be deter-
mined, e.g. by calculating the interobserver reliability.
Therefore two or more observers conduct the same test
and their accordance is subsequently analysed.
A few previous studies deal with interobserver reliability
[7-10]. Some of them by calculating the correlation coef-
ficients [7,10]. The value of such correlation coefficients
to determine interobserver reliability is limited, since level
differences remain unnoticed and extreme values can pre-
tend a higher reliability [11]. Smith et al. calculated the
intraclass correlation coefficient and the relative intertrial
variability (RIV) to determine interobserver reliability.
Special calculations apply for the RIV ([(IENFD1-
IENFD2)/MW (IENFD)] *100 [%]) and values less than 10%
indicate a high degree of reproducibility. Small absolute
differences at low IENFD values are presented as high per-
centage values while equivalent absolute differences at
high IENFD values are being presented as lower percent-
age values [9]. This approach can lead to an incorrect esti-
mation of the reliability. Gøransson et al. estimated the
interobserver reliability by calculating the absolute differ-
ence between the IENFD results of two observers.
Due to the limited suitability of the statistical methods so
far applied, there is still some need to adequately demon-
strate interobserver reliability of the IENFD determination
by skin biopsy. To achieve this, three independent observ-
ers analysed a sufficient quantity of biopsies. Addition-
ally, more appropriate statistical methods were chosen in




Skin biopsies from 68 patients were examined, who all
previously participated in several independent studies
designed to examine the validity of QST and to determine
the IENFD in skin biopsy. Patients suffered from polyneu-
ropathy (n = 23), fibromyalgia (n = 18), arthritis (n = 13)
or neuropathic pain after nerve injury at the lower limb (n
= 14). The duration of symptoms of patients with nerve
injury ranged from 14 to 294 months, with a median of
46 months. Affected nerves were either the common or
superficial peroneal nerve (n = 11) or the lateral cutane-
ous nerve of the thigh (n = 3). The age of all patients
ranged from 21 to 74 years (mean 52 ± 13 years) (Table
1). All studies were approved by the local ethics commit-
tee of the Ruhr University Bochum and the patients gave
written informed consent.
2.2 Skin biopsy
The procedure of skin biopsy followed the protocol by
Vlckova-Moravcova et al. [12], as a modified version of
the original Guidelines of the EFNS [6]. Indirect immun-
ofluorescence technique was used. Two samples were
taken from each patient, one from the affected and one
from an unaffected skin area. In patients with polyneu-
ropathy, fibromyalgia and arthritis biopsies were there-
fore carried out from dorso-lateral foot and back
(dermatome L4). The very distal biopsy site at the foot was
chosen because all patients had complaints at this area,
but not all had complaints at the lower leg, which would
be the standard biopsy site recommended by the EFNS
guidelines. As a level A recommendation those guidelines
also suggest the sampling of an additional biopsy from an
unaffected site in patients with generalised diseases to
provide information about a length-dependent process.
L4 dermatome was assessed as a second area, which was
the least affected area in most of the patients. In patients
with nerve injury biopsies were carried out bilaterally
from foot (dorsolateral or dorsomedial) or lateral thigh.
After local injection of 2% lidocaine the removal was car-
ried out under sterile conditions with a 3 mm biopsy
punch (Stiefel GmbH, Offenbach, Germany). Tissue was
fixed in 4% phosphate-buffered paraformaldehyde for 3–
4 hours and cryoprotected in 10% sucrose at 4°C over-
night. Subsequently the skin samples were embedded in
TissueTek®, frozen in 2-methylbutane cooled in liquid
Table 1: Demographic characteristics of patients with polyneuropathy, nerve injury at the lower limb, fibromyalgia and arthritis
Diagnosis Polyneuropathy Nerve injury Fibromyalgia Arthritis Total
Number of subjects (n) 23 14 18 13 68
Age (year), Mean ± SD 58.96 ± 10.62 41 ± 13.29 49.06 ± 10.25 57.23 ± 10.19 52.31 ± 13.07
Age (year), Range 36–74 21–67 27–68 26–68 21–74
Sex, Male (n) 13 11 4 3 31BMC Neurology 2009, 9:13 http://www.biomedcentral.com/1471-2377/9/13
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nitrogen and stored at 70°C until further processing. Sec-
tions of 40 μm thickness were cut on a sliding microtome
and immunostained with rabbit polyclonal antibodies to
human PGP 9.5 (Ultraclone, UK, 1:800) as primary anti-
body and marked with Cyanine 3 (Jackson Immuno
Research, USA). The intraepidermal nerve fibers were
counted manually in two sections of approximately 3 mm
length each by three independent observers (MF, ISH,
SW), who were professionally trained at an approved skin
biopsy laboratory (Department of Neurology, University
of Würzburg, Germany). Counting was conducted in a
blinded fashion to determine interobserver reliability at
400× magnification with a Zeiss Axiophot 2 microscope
adhering to standard counting rules [13], agreed on by the
European guidelines 2005 [6]. Samples were only evalu-
ated if the staining quality of both sections were judged to
be satisfactory by all observers (e.g. distinct discrimina-
tion of dermis and epidermis, clearly illustrated nerve fib-
ers). Samples were excluded for the determination of
interobserver reliability if they were judged to be of bad
quality for counting by at least one observer (e.g. nerve
fibers or basement membrane stained badly). Using
Image Pro Plus 4.0 software (Media Cybernetics, Leiden,
The Netherlands), the epidermal length was accurately
measured. The average intraepidermal nerve fiber density
(IENFD) per mm of epidermal length was then calculated.
IENFD results from biopsies taken from the foot were
compared with published control data [12] as done in a
previous study [4] and classified as pathologic in case of
IENFD less than 9 fibers/mm.
Additionally every observer evaluated the definition of the
basement membrane in each biopsy, classifying it as
'well', 'moderately' or 'inexactly' defined. In summary the
basement membrane was rated 'well defined' if at least
two observers ranked it so.
2.3 Data analysis
All statistical analyses were performed using the Statistica
software package, release 7.1 for Windows (StatSoft Inc.,
USA) and the statistical package for social sciences (SPSS
12). Differences between observers were analysed using a
one-way analysis of variance (ANOVA). Due to the
unprovable homogeneity of variance post hoc compari-
sons were calculated using Dunnet T3 post hoc tests. P val-
ues < 0.05 were considered significant. Since IENFD from
adjacent sections of one biopsy showed a high degree of
association [7], the accuracy of each observer was esti-
mated by calculating the standard deviation between both
sections of one biopsy (intersection variability) and the
relative standard deviation (SD/mean). To demonstrate
the variance growing with rising mean the results were
presented as Bland Altman Plot [14]. Interobserver relia-
bility was measured by calculating intraclass correlation
coefficient with absolute agreement definition [15]. To
compare the results of this study with those of previous
studies correlation coefficients and RIV were also meas-
ured. For the RIV applies ([(IENFD1-IENFD2)/MW (IENFD)]
*100 [%]) and values of less than 10% indicate a high
degree of reproducibility [9].
Results
A total of 120 biopsies from 68 patients (polyneuropathy:
n = 44; nerve injury at the lower limb: n = 25; fibromyal-
gia: n = 30; athritis: n = 21) were analysed. 16 biopsies had
to be excluded due to bad quality.
Evaluation of the complete data showed a significant dif-
ference between the IENFD counted by different observers
(Table 2). Variance increased with rising mean (Figure 1).
However, even at low IENFD values, e.g. in biopsies taken
from the foot, the difference between the observers
remained significant. Overall, observer 2 counted the
highest values for all biopsy sites, whereas observer 3
stated the lowest values for all biopsy sites. In conformity
with these results the Post Hoc tests revealed that in all
cases the significant difference laid only between these
two observers.
The intersection variability differed significantly between
the observers for the foot data and the complete data.
Observer 3 had the lowest values in contrast to observer 2
who had the highest ones (table 2). In this case the Post
Hoc tests revealed a significant difference between
observer 3 and both other observers for the foot data.
However, with respect to the overall data the intersection
variability differed significantly between observer 2 and 3.
The comparison of IENFD results of 71 foot biopsies with
published control data showed that the significant inter-
observer difference would generate different rates of path-
ological results. The results from observer 3 would add up
to 68 pathological biopsies in opposition to the other
observers with lower numbers of pathological biopsies
(62 and 63 respectively). Since the control data were taken
from the distal calf [12] the accuracy of the comparison
results might be limited.
The intraclass correlation coefficient for all data was 0.73.
Due to the significant difference between the observers
the correlation coefficients (Figure 2 + 3) and RIV with
participation of observer 3 showed the lowest values. The
RIV was 35.6% between observer 1 and 2, 61% between
observer 1 and 3 and 63.8% between observer 2 and 3.
The basement membrane has been rated as "well
defined"in 35 biopsies. Observer 3 also found lower val-
ues for these biopsies than the other observers, but the dif-
ference was not significant (Table 3). Correlation
coefficients changed and especially those with observer 3BMC Neurology 2009, 9:13 http://www.biomedcentral.com/1471-2377/9/13
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showed higher values (observer 1/2: r = 0,85; observer 1/
3: r = 0,8; observer 2/3: r = 0,85). The intraclass correlation
coefficient increased sligthly (0.77) as well.
Discussion
Our results revealed an unexpected significant difference
in IENFD between three observers. Despite having
received the same training, the three observers most likely
interpreted the standard counting rules [13] differently.
Due to a less clear and accurate staining of the skin inner-
vation in microscopic sections an observer might have dif-
ficulties to count the intraepidermal nerve fibers exactly
according to the counting rules. This problem occured in
biopsies with low IENFD values (figure 4) as well as in
biopsies with high IENFD values (figure 5). Some observ-
ers tended to a broader interpretation (Figure 4: 2 fibers,
figure 5: 11 fibers) of the counting rules, whilst others
interpreted them more strictly (Figure 4: 0 fibers, figure 5:
7 fibers). From a clinical point of view broader interpreta-
tion bears the risk of missing pathological biopsies (low
sensitivity, high specifity), whereas stricter interpretation
implicates the risk to rate healthy biopsies as pathological
(low specifity, high sensitivity). The different frequencies
of pathological values in the foot biopsies in this study
underline that this might be a relevant problem in clinical
diagnostics.
Since we found the lowest values of intersection variabil-
ity and therefore the highest accuracy for the observer stat-
ing the lowest IENFD values, the strict interpretation
might be more reliable.
Other groups stated higher interobserver reliability with
correlation coefficients ranging from 0.86–0.96 [7,10]. In
further studies the RIV was 9.6%, the intraclass correlation
coefficient 0.98 [9] and the mean difference between the
IENFD results of two observers 0.4 ± 1.5 fibers/mm [8].
The low interobserver reliability in our study was proba-
bly caused by the described significant interobserver dif-
ference in IENFD. Additionally we might have found
higher interobserver reliability by counting three sections
Table 2: IENFD by different observers for skin biopsy sites foot, back and thigh and total data
Skin biopsy site Observer 1 Observer 2 Observer 3 Significance
Foot, n = 71 IENFD [fibers/mm] IENFD [fibers/mm] IENFD [fibers/mm] p
Mean ± SD 4.88 ± 4.1 5.16 ± 4.00 3.57 ± 2.56 *
Range 0–22.8 0–23.8 0–13.21 -
Median 3.90 4.04 3.02 -
25–75% percentile 2.17–6.55 2.66–6.61 1.93–4.59 -
Inter section SD 0.76 0.84 0.5 **
Relative inter section SD 0.21 0.21 0.17 -
Back, n = 45 IENFD [fibers/mm] IENFD [fibers/mm] IENFD [fibers/mm] -
Mean ± SD 15.97 ± 11.63 17.74 ± 11.73 12.20 ± 4.78 *
Range 0–56.08 0.54–55.61 1.7–22.88 -
Median 11.92 16.21 11.95 -
25–75% percentile 7.78–21.8 7.32–24.44 9.06–15.18 -
Inter section SD 1.67 2.09 1.16 -
Relative inter section SD 0.1 0.15 0.11 -
Thigh, n = 4 IENFD [fibers/mm] IENFD [fibers/mm] IENFD [fibers/mm] -
Mean ± SD 4.15 ± 2.49 5.69 ± 4.21 2.12 ± 2.68 -
Range 1.38–8.13 2.07–12.86 0.19–6.68 -
Total, n = 120 IENFD [fibers/mm] IENFD [fibers/mm] IENFD [fibers/mm] -
Mean ± SD 9.01 ± 9.48 9.89 ± 9.93 6.76 ± 5.52 *
Range 0–56.08 0–55.61 0–22.88 -
Median 5.51 6.29 4.86 -
25–75% percentile 3.1–11.2 3.69–12.37 2.31–11.14 -
Inter section SD 1.11 1.31 0.74 *
Relative inter section SD 0.17 0.19 0.16 -
Significance: * p < 0.05 ** p < 0.01BMC Neurology 2009, 9:13 http://www.biomedcentral.com/1471-2377/9/13
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Bland Altman Plot for all biopsies (n = 120) Figure 1
Bland Altman Plot for all biopsies (n = 120).
Correlation between IENFD measured by three independent observers for all biopsies (n = 120) (Correlation coefficients for  observer 1/2 and 1/3) Figure 2
Correlation between IENFD measured by three independent observers for all biopsies (n = 120) (Correlation 
coefficients for observer 1/2 and 1/3).BMC Neurology 2009, 9:13 http://www.biomedcentral.com/1471-2377/9/13
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as recommended by the EFNS Guidelines [6]. Considering
the pronounced significant difference between the observ-
ers in our study, the results would have probably been
similar. Furthermore an accessory analysis of intra-
observer reliability would allow a more accurate interpre-
tation of the interobserver reliability.
The qualitative evaluation of the basement membrane
before counting the intraepidermal nerve fibers could be
an approach to improve the methodical accuracy. The
results allow the conclusion that interobserver reliability
is higher if the basement membrane is well defined. Con-
sequently skin biopsies with inexact illustration of the
basement membrane should not be used for the determi-
nation of IENFD in clinical diagnostics and scientific stud-
ies. However the number of biopsies with a well defined
basement membrane was quite small in our study and
there was only a little improvement of interobserver relia-
bility.
Another possibility to avoid inaccurate IENF counting due
to an inexactly defined basement membrane might be the
use of antibodies against collagen IV with confocal micro-
scopy to better visualise the basement membrane [6].
Conclusion
In summary, the determination of IENFD by skin biopsy
is a useful method to investigate different types of periph-
eral neuropathy [16], but our results show that standardi-
sation of the method is extremely important. However the
number of biopsies was quite small in our study and we
used a modified version of the original Guidelines of the
EFNS. Therefore our results are limited to a small number
of patients but lead us to following conclusion. To avoid
Correlation between IENFD measured by three independent observers for all biopsies (n = 120) Figure 3
Correlation between IENFD measured by three independent observers for all biopsies (n = 120). (Correlation 
coefficient for observer 2/3).
Table 3: IENFD by different observers for punches with well 
defined dermal-epidermal basement membrane (n = 35).
Observer 1 Observer 2 Observer 3
Mean ± SD 8.74 ± 7.72 9.82 ± 7.93 6.85 ± 5.2
Range 0–27.41 0–27.41 0.52–16.22
Median 7.12 7.04 5.02
25–75% percentile 2.17–12.32 3.66–14.21 2.31–11.95
No significant difference between observersBMC Neurology 2009, 9:13 http://www.biomedcentral.com/1471-2377/9/13
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inaccurate IENFD counting, clear inclusion and exclusion
criteria for skin biopsy samples should be further defined.
The EFNS Guidelines [6] recommend the application of
the counting protocol which was described by Kennedy et
al [13]. Our results show that a consensus should be
reached on the interpretation of the counting rules in
biopsies with less accurate illustration of the skin innerva-
tion. We recommend that observers undergo thorough
training and intraobserver reliability must be demon-
strated by intra-lab assessment to avoid different interpre-
tation of the counting rules by individuals. Nevertheless
IENFD counting may still be a subjective investigation
partially. Skin biopsies with critical IENFD values (IENFD
near the cut-off values) should be analysed by at least two
observers together. Furthermore, mandatory external
quality controls of skin biopsy laboratories e.g. by inter-
laboratory comparison should be enforced. Whilst in
experienced laboratories the interobserver reliability may
not an issue, consensus data is still needed for application
to all labs.
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